Biocept, Inc. Profile Avatar - Palmy Investing

Biocept, Inc.

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthc…

Medical - Diagnostics & Research
US, San Diego [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of BIOC's Analysis
CIK: 1044378 CUSIP: 09072V402 ISIN: US09072V6002 LEI: - UEI: -
Secondary Listings
BIOC has no secondary listings inside our databases.